Researcher Publication Search

Name: anne fagan
Year: 2014

Reference:

Brier MR, Thomas JB, Fagan AM, Hassenstab J, Holtzman DM, Benzinger TL, Morris JC, Ances BM. Functional connectivity and graph theory in preclinical Alzheimer’s disease. Neurobiol Aging. 2014 35:757-68. PMID:24216223

Name: Anne Fagan
Year: 2014

Reference:

Brier MR, Thomas JB, Snyder AZ, Wang L, Fagan AM, Benzinger T, Morris JC, Ances BM. Unrecognized preclinical Alzheimer disease confounds rs-fcMRI studies of normal aging Neurology. 2014 Oct 28;83(18):1613-9. PMCID: PMC4223085

Name: Alison Goate
Year: 2014

Reference:

Escott-Price V, Bellenguez C, Wang LS, Choi SH, Harold D, Jones L, Holmans P, Gerrish A, Vedernikov A, Richards A, DeStefano AL, Lambert JC, Ibrahim-Verbaas CA, Naj AC, Sims R, Jun G, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thornton-Wells TA, Denning N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Schmidt H, Kunkle B, Dunstan ML, Vronskaya M; United Kingdom Brain Expression Consortium, Johnson AD, Ruiz A, Bihoreau MT, Reitz C, Pasquier F, Hollingworth P, Hanon O, Fitzpatrick AL, Buxbaum JD, Campion D, Crane PK, Baldwin C, Becker T, Gudnason V, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letenneur L, Hernández I, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fiévet N, Huentelman MJ, Gill M, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuinness B, Larson EB, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Rogaeva E, Gallacher J, George-Hyslop PS, Clarimon J, Lleo A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossù P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Garcia FS, Fox NC, Hardy J, Naranjo MC, Bosco P, Clarke R, Brayne C, Galimberti D, Scarpini E, Bonuccelli U, Mancuso M, Siciliano G, Moebus S, Mecocci P, Zompo MD, Maier W, Hampel H, Pilotto A, Frank-García A, Panza F, Solfrizzi V, Caffarra P, Nacmias B, Perry W, Mayhaus M, Lannfelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alvarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Gu W, Razquin C, Pastor P, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O’Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH Jr, Bennett DA, Harris TB, Fratiglioni L, Holmes C, de Bruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltunen M, Martin ER, Schmidt R, Rujescu D, Dartigues JF, Mayeux R, Tzourio C, Hofman A, Nöthen MM, Graff C, Psaty BM, Haines JL, Lathrop M, Pericak-Vance MA, Launer LJ, Van Broeckhoven C, Farrer LA, van Duijn CM, Ramirez A, Seshadri S, Schellenberg GD, Amouyel P, Williams J. Gene-wide analysis detects two new susceptibility genes for Alzheimer’s disease. PLoS One. 2014; 9(6):e94661. PMCID: PMC4055488.

Name: Alison Goate
Year: 2014

Reference:

Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Chetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, SallowayS, Schofield PR, Sperling RA, Marcus D, Cairns NJ, Buckles VD, Ladenson JH, Morris JC, Holtzman DM, Dominanty Inherited Alzheimer Network. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer’s Disease. Sci Transl Med 2014: 6(226):226ra30. PMCID: PMC4038930.

Name: Anne Fagan
Year: 2014

Reference:

Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Salloway S, Schofield PR, Sperling RA, Marcus D, Cairns NJ, Buckles VD, Ladenson JH, Morris JC, Holtzman DM; Dominantly Inherited Alzheimer Network. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer’s disease. Sci Transl Med. 2014 Mar 5;6(226):226ra30. doi: 10.1126/scitranslmed.3007901. PMID:24598588

Name: Nigel Cairns
Year: 2014

Reference:

Gallagher MD, Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer JD, Halliday G, Van Broeckhoven C, Seilhean D, Shaw PJ, Frosch MP, Alafuzoff I, Antonell A, Bogdanovic N, Brooks W, Cairns NJ, Cooper-Knock J, Cotman C, Cras P, Cruts M, De Deyn PP, Decarli C, Dobson-Stone C, Engelborghs S, Fox N, Galasko D, Gearing M, Gijselinck I, Grafman J, Hartikainen P, Hatanpaa KJ, Highley JR, Hodges J, Hulette C, Ince PG, Jin LW, Kirby J, Kofler J, Kril J, Kwok JB, Levey A, Lieberman A, Llado A, Martin JJ, Masliah E, McDermott CJ, McKee A, McLean C, Mead S, Miller CA, Miller J, Munoz DG, Murrell J, Paulson H, Piguet O, Rossor M, Sanchez-Valle R, Sano M, Schneider J, Silbert LC, Spina S, van der Zee J, Van Langenhove T, Warren J, Wharton SB, White Iii CL, Woltjer RL, Trojanowski JQ, Lee VM, Van Deerlin V, Chen-Plotkin AS. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol. 2014 Jan 19. [Epub ahead of print]

Name: Nupur Ghoshal
Year: 2014

Reference:

Ghoshal N, Perry A, McKeel D, Schmidt RE, Carter D, Norton J, Zou WQ, Xiao X, Puoti G, Notari S, Gambetti P, Morris JC, Cairns NJ. Variably Protease-sensitive Prionopathy in an Apparent Cognitively Normal 93-Year-Old. Alzheimer disease and associated disorders. May 19 2014. PMID: 24845762 NIHMS587913

Name: Brian Gordon
Year: 2014

Reference:

Gordon, BA, Blazey, T, Benzinger, TLS. Regional variability in Alzheimer’s disease biomarkers. Future Neurology 2014; 9(2): 131-134

Name: Alison Goate
Year: 2014

Reference:

Harari O, Cruchaga C, Kauwe JS, Ainscough BJ, Bales K, Pickering EH, Bertelsen S, Fagan AM, Holstman DM, Morris JC, Goate AM; Alzheimer’s Disease Neuroimaging Initiative. Phosphorylated tau-Aß42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer’s Disease in multiplex immunossasay panels of cerebrospinal fluid. Biol Psychiatry 2014; 75(9):723-31. PMCID: PMC4007142

Name: Anne Fagan
Year: 2014

Reference:

Harari O, Cruchaga C, Kauwe JS, Ainscough BJ, Bales K, Pickering EH, Bertelsen S, Fagan AM, Holtzman DM, Morris JC, Goate AM; Alzheimer’s Disease Neuroimaging Initiative. Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer’s disease in multiplex immunoassay panels of cerebrospinal fluid. Biol Psychiatry. 2014 May 1;75(9):723-31. doi: 10.1016/j.biopsych.2013.11.032. Epub 2014 Jan 19. PMCID: PMC4207667

Name: David Carr
Year: 2014

Reference:

Hetland AJ, Carr DB, Wallendorf MJ, Barco PP. ‘Potentially Driver Impairing’ PDI Medication Use in Medically Impaired Adults Referred for Driving Evaluation. Ann Pharmacother. 2014 Jan 28. Epub ahead of print PMID:24473491

Name: David Carr
Year: 2014

Reference:

Hetland AJ, Carr DB. Medications and Impaired Driving: A Review of the Literature. Ann Pharmacother. 2014 Jan 28. [Epub ahead of print] PMID:24473486

Name: Nigel Cairns
Year: 2014

Reference:

Holmes BB, Furman JL, Mahan TE, Yamasaki TR, Mirbaha H, Eades WC, Belaygorod L, Cairns NJ, Holtzman DM, Diamond MI.Proteopathic tau seeding predicts tauopathy in vivo.Proc Natl Acad Sci U S A.2014 Oct 14;111(41):E4376-85. doi: 10.1073/pnas.1411649111. Epub 2014 Sep 26

Name: Alison Goate
Year: 2014

Reference:

Jin SC, Benitez BA, Karch CM, Cooper B, Skorupa T, Carrell D, Norton JB, Hsu S, Harari O, CaiY, Bertelsen S, Goate AM, Cruchaga C. Coding variants in TREM2 increase risk for Alzheimer’s disease. Hum Mol Genet. 2014 Jun 4. IN PRESS

Name: Alison Goate
Year: 2014

Reference:

Karch CM, Goate AM. Biol Psychiatry. Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis. Biol Psychiatry 2014; May 17. IN PRESS

Name: Anne Fagan
Year: 2014

Reference:

Kauwe JS, Bailey MH, Ridge PG, Perry R, Wadsworth ME, Hoyt KL, Staley LA, Karch CM, Harari O, Cruchaga C, Ainscough BJ, Bales K, Pickering EH, Bertelsen S; Alzheimer’s Disease Neuroimaging Initiative, Fagan AM, Holtzman DM, Morris JC, Goate AM Genome-Wide Association Study of CSF Levels of 59 Alzheimer’s Disease Candidate Proteins: Significant Associations with Proteins Involved in Amyloid Processing and Inflammation. PLoS Genet. 2014 Oct 23;10(10):e1004758. PMCID: PMC4207667

Name: Tammie Benzinger
Year: 2014

Reference:

Kelly JE, Mar S, D’Angelo G, Zhou G, Rajderkar D, Benzinger TL. Susceptibility-weighted imaging helps to discriminate pediatric multiple sclerosis from acute disseminated encephalomyelitis. Pediatric neurology. 2015;52(1):36-41. Epub 2014/12/24. doi: 10.1016/j.pediatrneurol.2014.10.014. PubMed PMID: 25532777; PubMed Central PMCID: PMC4275621.

Name: Cairns Nigel
Year: 2014

Reference:

Monsell SE, Mock C, Hassenstab J, Roe CM, Cairns NJ, Morris JC, Kukull W.Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology.
Neurology. 2014 Jul 29;83(5):434-40. doi: 10.1212/WNL.0000000000000650. Epub 2014 Jun 20.
PMID:24951474

Name: Anne Fagan
Year: 2014

Reference:

O’ Bryant SE, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S, Bazenet C,
Soares H, Lovestone S, Hampel H, Montine T, Blennow K, Foroud T, Carrillo M, Graff-Radford N, Laske C, Breteler M, Shaw L, Trojanowski JQ, Schupf N, Rissman RA, Fagan AM, Oberoi P, Umek R, Weiner MW, Grammas P, Posner H, Martins R, STAR-B and BBBIG working groups. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer’s disease research. Alzheimers Dement. 2014 Sep 27. PMCID: PMC4414664

Name: Alison Goate
Year: 2014

Reference:

Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, Lopera F, Martins R, Masters CL, Mayeux RP, McDade E, Moreno S, Reiman EM, Ringman JM, Salloway S, Schofield PR, Sperling R, Tariot PN, Xiong C, Morris JC, Bateman RJ; And the Dominantly Inherited Alzheimer Network. Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis. Neurology. 2014; 83(3):253-60. PMCID: PMC4117367.

Name: Nupur Ghoshal
Year: 2014

Reference:

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR, Bapineuzumab, Clinical Trial I. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. The New England journal of medicine. Jan 23 2014;370(4):322-333. PubMed PMID: 24450891
*Ghoshal, N. Listed under Bapineuzumab 301 and 302 Clinical Trial Investigators

Name: Susan Stark
Year: 2014

Reference:

Stark SL, Silianoff TJ, Kim H, Conte JW, Morris JC. Tailored Calendar Journals to Ascertain Falls Among Older Adults. OTJR : occupation, participation and health. Forthcoming; NIHMSID#642589

Name: david balota
Year: 2014

Reference:

Storandt M, Balota DA, Aschenbrenner AJ, Morris JC. Clinical and psychological characteristics of initial cohort of the Dominantly Inherited Alzheimer Network (DIAN). Neuropsychology 2014; 1: 19-29. PMCID: PMC3877741.

Name: Tammie Benzinger
Year: 2014

Reference:

Su Y, Blazey TM, Snyder AZ, Raichle ME, Marcus DS, Ances BM, Bateman RJ, Cairns NJ, Aldea P, Cash L, Christensen JJ, Friedrichsen K, Hornbeck RC, Farrar AM, Owen CJ, Mayeux R, Brickman AM, Klunk W, Price JC, Thompson PM, Ghetti B, Saykin AJ, Sperling RA, Johnson KA, Schofield PR, Buckles V, Morris JC, Benzinger TL. Partial volume correction in quantitative amyloid imaging. NeuroImage. 2015;107:55-64. Epub 2014/12/09. doi: 10.1016/j.neuroimage.2014.11.058. PubMed PMID: 25485714; PubMed Central PMCID: PMC4300252.

Name: Anne Fagan
Year: 2014

Reference:

Sutphen CL, Jasielec MS, Shah AR, Macy EM, Xiong C, Vlassenko AG, Benzinger TL, Stoops EE, Vanderstichele HM, Brix B, Darby HD, Vandijck ML, Ladenson JH, Morris JC, Holtzman DM, Fagan AM. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age. JAMA Neurol. 2015 Jul 6. doi: 10.1001/jamaneurol.2015.1285. [Epub ahead of print] PubMed PMID: 26147946